Orserdu 345 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FKE70
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,842
Award facts
- Contract value 100% obligated
- $27,841.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,841.82 delivery order to AmerisourceBergen Drug Corp for ORSERDU 345 mg tablets (30-count units) with a firm fixed price contract type. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of October 21, 2025. Performance will be executed from the awardee's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company maintains a comprehensive pharmaceutical portfolio encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The DLA Troop Support Medical relationship enables AmerisourceBergen to supply pharmaceutical products globally to support military healthcare programs, while the company also serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for ORSERDU tablets exemplifies the company's ongoing role in fulfilling federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FKE70?
SPE2DB25FKE70 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FKE70 worth?
The government has obligated $27,842 on SPE2DB25FKE70.
Is contract SPE2DB25FKE70 an order under another contract?
Yes. SPE2DB25FKE70 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKE70 competed?
The extent of competition for SPE2DB25FKE70 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award